These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9687109)

  • 21. [Sensitivity of anaerobes in gyneco-obstetric infections].
    Guerrero B; Valenzuela ME; Sanhueza A
    Rev Chil Obstet Ginecol; 1978; 43(5):283-7. PubMed ID: 232934
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical study of cefpirome sulphate in obstetric and gynaecological infections.
    Sagawa T; Fuiuno T; Sakuragi N; Kishida T; Yamada H; Fuiimoto S
    J Int Med Res; 2000; 28(6):288-99. PubMed ID: 11191722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of ciprofloxacin in gynaecological infections.
    Loendersloot E; Branolte JH
    J Chemother; 1989 Jul; 1(4 Suppl):888-9. PubMed ID: 16312688
    [No Abstract]   [Full Text] [Related]  

  • 24. [Fundamental and clinical studies of cefpiramide in the field of obstetrics and gynecology].
    Ninomiya K; Ohbayashi F; Hasegawa Y
    Jpn J Antibiot; 1985 Aug; 38(8):2360-6. PubMed ID: 4079009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and laboratory evaluation of cefoperazone.
    Sarver DK; Christensen GD; Hester MG; Ling FW; Pate JW; Rosenberg EW; Anderson GD; Bisno AL
    Clin Ther; 1981; 4(3):164-74. PubMed ID: 6458360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical trial of cefpiramide in the gynecological field].
    Obata I; Hayashi F; Imagawa N; Ochiai K; Koike K; Morimoto O; Hachiya S
    Jpn J Antibiot; 1985 Sep; 38(9):2387-96. PubMed ID: 4079012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fundamental and clinical studies on cefuzonam in the field of obstetrics and gynecology].
    Yamamoto T; Yasuda J; Kanao M; Okada H
    Jpn J Antibiot; 1987 May; 40(5):1074-83. PubMed ID: 3669286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized comparative study of cefepime and cefotaxime in the treatment of acute obstetric and gynaecological infections.
    Newton ER; Yeomans ER; Pastorek JG; Soper DE; Hemsell DL
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():195-204. PubMed ID: 8150763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Broad-spectrum cephalosporins].
    Goldstein FW
    Presse Med; 1998 Jul 4-11; 27(24):1256-8. PubMed ID: 9767792
    [No Abstract]   [Full Text] [Related]  

  • 30. The treatment of gynaecological and intra-abdominal infections: a comparative study of cefotetan versus netilmicin plus clindamycin.
    Poularas J; Giamarellou H; Vlachos G; Theakou R; Patoulis J; Lekakos N; Stavridis J; Sfikakis P
    J Chemother; 1989 Jul; 1(4 Suppl):880-1. PubMed ID: 16312684
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical studies of flomoxef in the field of obstetrics and gynecology].
    Doko F
    Jpn J Antibiot; 1987 Oct; 40(10):1830-4. PubMed ID: 3444024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aztreonam.
    Clark P
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):519-28. PubMed ID: 1436929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo activity of DQ-2556, a new cephalosporin.
    Ishida Y; Miyazaki S; Yamaguchi K; Goto S
    Chemotherapy; 1995; 41(1):5-13. PubMed ID: 7875022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the activity of meropenem with that of other agents in the treatment of intraabdominal, obstetric/gynecologic, and skin and soft tissue.
    Pitkin D; Sheikh W; Wilson S; Hemsell D; Nichols R; Nadler H; Dowzicky M
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S372-5. PubMed ID: 7548602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical effect of cefuzonam and its distribution into tissues in the field of obstetrics and gynecology].
    Suzuki T; Ohtsuka T; Uemura T; Minaguchi H
    Jpn J Antibiot; 1987 Oct; 40(10):1745-51. PubMed ID: 3444014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The modern view of cephalosporin antibiotics].
    Hejzlar M
    Cesk Pediatr; 1984 Apr; 39(4):218-20. PubMed ID: 6733798
    [No Abstract]   [Full Text] [Related]  

  • 37. Ceftizoxime (FK749), a new cephalosporin with a potent in-vitro activity against Gram-negative bacilli.
    Ogawa M; Hama M; Takata N; Kosaki G; Suginaka H
    J Antimicrob Chemother; 1981 Jun; 7(6):673-6. PubMed ID: 6941959
    [No Abstract]   [Full Text] [Related]  

  • 38. [Oral cephalosporins in the treatment of suppurative-inflammatory diseases].
    Sidorenko SV
    Antibiot Khimioter; 1996; 41(11):33-42. PubMed ID: 9214285
    [No Abstract]   [Full Text] [Related]  

  • 39. Cefmenoxime therapy for gynecologic and obstetric infections.
    Rao B; Savage EW; Chuah SK; Bansal MB; Dhawan VK; Thadepalli H
    Obstet Gynecol; 1985 Sep; 66(3):377-83. PubMed ID: 3860790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical efficacy of cefpirome sulfate against Bacteroides species, Prevotella species and Porphyromonas species. Society of Anaerobic Bacterial Infections in the fields of obstetrics and gynecology in Gifu].
    Mikamo H; Sato Y; Hayasaki Y; Hua YX; Tamaya T; Iwasa S; Kawazoe K; Furuta N; Ito M; Nomura M; Tsukahara Y; Furui K; Sakakibara K; Hattori S; Sugiyama M; Ohnishi N; Hirose R; Nakagawa M; Yamada Y; Hashiyama T; Arahori K; Izumi K; Shiraki S; Morishita S; Watanabe K
    Jpn J Antibiot; 2000 Jan; 53(1):26-45. PubMed ID: 10709144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.